Address: Kammakargatan 22 Stockholm SE-11-1140
Released:6/28/2017
Regulator:FDA
Nevisense is a device designed to assist dermatologists in detecting melanoma by measuring the electrical impedance of skin lesions. It helps provide additional information to decide whether a biopsy is necessary, aiming to improve early melanoma detection and reduce unnecessary biopsies.
View detailsSubscribe to join 10k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.
We respect your privacy. Unsubscribe at any time.